CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 30 filers reported holding CLOVIS ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $105,000 | -31.8% | 250,000 | 0.0% | 0.00% | – |
| Q2 2019 | $154,000 | -21.0% | 250,000 | 0.0% | 0.00% | – |
| Q1 2019 | $195,000 | +10.2% | 250,000 | 0.0% | 0.00% | – |
| Q4 2018 | $177,000 | -8.8% | 250,000 | 0.0% | 0.00% | – |
| Q3 2018 | $194,000 | -15.7% | 250,000 | 0.0% | 0.00% | – |
| Q2 2018 | $230,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Castle Creek Arbitrage, LLC | 3,000,000 | $1,874,000 | 0.49% |
| Opti Capital Management, LP | 4,500 | $2,815,000 | 0.42% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,000,000 | $18,578,000,000 | 0.36% |
| CAMDEN ASSET MANAGEMENT L P /CA | 17,336,000 | $10,785,000 | 0.34% |
| CSS LLC/IL | 5,850,000 | $3,650,000 | 0.21% |
| MIZUHO SECURITIES USA LLC | 4,000,000 | $2,504,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 18,750,000 | $11,684,000 | 0.08% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 4,516,000 | $2,834,000 | 0.06% |
| AQR Arbitrage LLC | 7,350,000 | $4,609,000 | 0.05% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 8,000 | $1,562,000 | 0.04% |